SDF for the Management of Dental Caries in Children in Primary Dental Care: Protocol for a Feasibility Study
Launched by SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST · Oct 13, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a treatment called silver diamine fluoride (SDF) to see if it is more effective than usual care for managing tooth decay in young children. Tooth decay, or dental caries, is a common problem that affects many children in the UK, causing pain and leading to hospital visits. The goal of the study is to understand if a larger trial comparing SDF to standard treatments can be successfully conducted in UK dental practices.
To be eligible for this study, children between the ages of 2 and 6 who have cavities in their baby teeth can participate, as long as the decay hasn’t reached the tooth's pulp or caused an infection. Parents or caregivers will need to provide consent for their child to join the trial. Participants will receive either SDF or usual care, and the study will follow them for one year to gather important information on how well each treatment works. Throughout the trial, families will be involved in providing feedback to help shape the study’s design and processes.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Children aged 2-6 years
- • Cavitated dentinal caries in any primary tooth
- • No carious involvement of the tooth pulp
- • No dental infection secondary to a non-vital tooth
- • Parent/carer able to complete consent forms (with the support of an interpreter if necessary)
- Exclusion Criteria:
- • Allergy to any treatment component
- • Caries effecting the pulp
- • Infection secondary to a non-vital tooth
- • Conditions requiring special considerations for the child's dental management where randomisation would not be appropriate for example a medical history including cardiac defects, oncology, hereditary bleeding, or being immunocompromised.
- • Dental anomalies effecting the carious teeth involved: amelogenesis imperfecta, dentinogenesis imperfecta, molar incisor hypomineralisation, abnormal morphology such as double teeth.
About Sheffield Teaching Hospitals Nhs Foundation Trust
Sheffield Teaching Hospitals NHS Foundation Trust is a leading healthcare institution in the UK, dedicated to delivering high-quality patient care, advancing medical research, and fostering education and training in the health sector. As a prominent sponsor of clinical trials, the Trust collaborates with various stakeholders to facilitate innovative research initiatives that aim to improve treatment outcomes and enhance patient safety. With a commitment to excellence, the organization leverages its extensive clinical expertise and resources to support the development of new therapies and interventions, ultimately contributing to the advancement of healthcare practices both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sheffield, , United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported